Ecolab Likely to Meet Q3 Expectations, Reaffirm Full-Year EPS Guidance, RBC Says

MT Newswires Live
Oct 14

Ecolab (ECL) is expected to report Q3 results in line with expectations and reaffirm its full-year earnings per share guidance as pricing tailwinds boost organic growth for the rest of the year, RBC Capital Markets said in a note Friday.

Analysts, including Ashish Sabadra, project about 4% organic revenue growth for Q3, likely driven by strength in high-tech, life sciences, institutional, and pest control businesses. Pricing could rise to around 3% in Q3 and Q4, supported by a 5% US tariff surcharge and value-based pricing strategies, analysts added.

For Q3, the analysts estimate adjusted earnings per share of $2.07, operating income of $796 million, and an operating margin of 19.3%, all in line with consensus, while revenue is likely to be slightly below consensus at $4.12 billion. For the full year, Ecolab is expected to confirm its EPS guidance for $7.42 to $7.62, RBC said.

Ecolab's continued focus on higher-growth areas such as data centers, microelectronics, life sciences, and digital offerings, as well as the Ovivo acquisition position the company for EPS growth of 12% to 15% in fiscal year 2026 and beyond, according to the note.

"We see Ecolab as a strong franchise given over 90% recurring revenues, long-term revenue growth of 5% to 7% and normalized EPS growth of 15% based on the razor/razor blade consumable model," analysts said.

The company is scheduled to report Q3 results on Oct. 28.

RBC has an outperform rating and a $294 price target on Ecolab.

Price: 271.93, Change: -0.15, Percent Change: -0.06

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10